首页> 外文OA文献 >Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version

【2h】

Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version

机译：2016年Chentradelphia染色体阴性髓样肿瘤的重新分类到2016年WHO诊断标准：专注于分类为肌酚肿瘤的病例，由2008年版本不可划分

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jiwon Yun; Jung-Ah Kim; Junseo Park; Kyongok Im; Young Eun Lee; Dajeong Jeong; Sohee Ryu; Kyu Min Lim; Sung-Min Kim; Yong-Oon Ahn; Dong Soon Lee;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version [J] . Iurlo Alessandra, Gianelli Umberto, Cattaneo Daniele, American Journal of Hematology . 2017,第4期

机译：2016年度对缅氏体瘤形成的标准的影响，无分配：与2008年版本的比较
2. CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms Primary Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera, and Myeloproliferative Neoplasm, Unclassifiable [J] . Kim Seon Young, Im Kyongok, Park Si Nae, American journal of clinical pathology. . 2015,第5期

机译：具有四个不同亚型的骨髓增生性肿瘤患者的CALR，JAK2和MPL突变谱原发性骨髓纤维化，原发性血小板增多症，真性红细胞增多症和骨髓增生性肿瘤，无法分类
3. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. [J] . Vannucchi AM, Masala G, Antonioli E Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research . 2009,第7期

机译：费城染色体阴性骨髓增生性肿瘤患者发生淋巴瘤的风险增加。
4. Study on the Correlation between Psychological Disorders, Clinical and Biological Parameters and the Evolution of Patients with Philadelphia Negative Chronic Myeloproliferative Neoplasms [C] . Mihaila R.G., Olteanu A., Lienerth D., European Association of Psychosomatic Medicine., Annual Meeting. . 2014

机译：心理障碍，临床和生物学参数与费城阴性慢性肌酚瘤肿瘤患者的相关性研究
5. Myeloproliferative Neoplasms: From Biology to Targeted Therapeutics [D] . Marinaccio, Christian. 2021

机译：Myeloproiferative肿瘤：从生物学到靶向治疗
6. Response to the letter by Langabeer on Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria [O] . Ik-Chan Song 2020

机译：回应Langabeer关于使用经修订的2016年世界卫生组织诊断标准揭示的脑梗死患者的费城阴性骨髓增生性肿瘤进行回顾性筛查的信
7. Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version [O] . Alessandra Iurlo, Umberto Gianelli, Daniele Cattaneo, 2017

机译：2016年2016年的影响修订了谁是肌酚肌肉瘤，无分配的标准：与2008年版本的比较

Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version

著录项

引文网络

相似文献

相关主题

期刊订阅